TurboInnovate Partners with Intelligence Ventures to Bring AI-Powered Predictions to Investment Diligence
The collaboration brings TurboInnovate's consultant-grade market intelligence to investors, startups, venture studios, university technology transfer offices, and accelerators across the deep tech and life science ecosystem.
Under the partnership, Intelligence Ventures will integrate TurboInnovate directly into its deal evaluation workflow to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage companies. Beyond the platform itself, TurboInnovate's team will provide hands-on commercialization support to select Intelligence Ventures portfolio companies.
"Most investment firms rely blindly on referral deal flow and make gut instinct-based emotional decisions. The innovation ecosystem has long relied on such private networks to identify and support the most promising early-stage opportunities. TurboInnovate adds a critical layer of validated, comprehensive and objective data to that process," said Dr.
"Intelligence Ventures was built on the thesis that proprietary data is the only durable moat in AI healthcare—and we hold ourselves to that same standard. We've reviewed over 630 companies across 19 market segments and published the State of AI Healthcare report as a byproduct of how we underwrite. TurboInnovate extends that edge. It delivers in minutes what used to require a six-figure consulting engagement: validated competitive landscapes, IP depth, funding trajectories, and federal market signals, all contextually matched to the technology in question. For a data-driven fund like ours, adoption wasn't a question," said
About OmniSync Incorporated
OmniSync is a
About Intelligence Ventures
Intelligence Ventures backs early-stage founders building AI-powered healthcare companies with proprietary data moats. Operating Intelligence Ventures Fund I, the firm invests at the pre-seed and seed stages across biotech and pharma tools, diagnostics, medical devices, and healthcare SaaS, with check sizes of $25K–$50K in the US and
Intelligence Ventures Fund I is offered exclusively to accredited investors under Rule 506(c) of Regulation D. This press release is not an offer to sell or a solicitation of an offer to buy any security. For important disclosures, please visit intelligencevc.com.
Media Contact:
858-264-6546
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/turboinnovate-partners-with-intelligence-ventures-to-bring-ai-powered-predictions-to-investment-diligence-302748132.html
SOURCE OmniSync Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NACCO INDUSTRIES APPOINTS PATRICK J. BURNS TO BOARD OF DIRECTORS
- Oracle Health Expands Clinical AI Agent with Automated Coding, Dictation, and Chart Review
- Home Lenders Enhance Digital Impact with Accelerated Closing and Funding, Relationship Value-Adds and Visual Consumer-Education Content
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share